Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival.

Luigi D'Antonio,Cristiano Fieni,Stefania Livia Ciummo,Simone Vespa,Lavinia Lotti,Carlo Sorrentino,Emma Di Carlo

Journal for immunotherapy of cancer（2023）

Cited 3|Views14
No score
Abstract
IL30 is a new CRC driver, since its inactivation, which disables oncogenic pathways and multiple autocrine loops, inhibits CR-CSC tumorigenicity and metastatic ability. The development of CRISPR/Cas9-mediated targeting of IL30 could improve the current therapeutic landscape of CRC.
More
Translated text
Key words
cytokines,gastrointestinal neoplasms
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined